IMEXHS Secures AU$2.5 million to Drive Growth of AI-Enabled Aquila Platform

IMEXHS Limited (ASX: IME) has secured AU$2.5 million in funding through a Placement and Conditional Placement aimed at accelerating the growth of its AI-enabled software platform, Aquila+, and strengthening working capital. The Company has received AU$1.5 million in binding commitments from institutional and sophisticated investors and an additional AU$1.0 million via a Conditional Placement to directors and their associated entities.

Additionally, a Share Purchase Plan will raise to AU$1.0 million, with all shares issued at AU$0.35 per share, representing an 11.4% discount to the last closing price. CEO Dr. German Arango emphasized the Company’s commitment to delivering a profitable and cash-positive year in 2025, focusing on improving margins in its radiology services business. IMEXHS is also in advanced negotiations for a significant radiology contract with a public hospital district in Bogotá, Colombia. The Placement settlement is set for 11 April 2025, with the Conditional Placement subject to approval at the AGM on 19 May 2025.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com